MICHELLE HATHAWAY: Open Payments
NPI 1558798702 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 71 payments from 15 companies in 2025. Trend: 2023 $1,540 · 2024 $1,484 · 2025 $1,175
Food & beverage: $1,096Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $382 |
| Regeneron Healthcare Solutions, Inc. | 9 | $215 |
| GENZYME CORPORATION | 7 | $136 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Philips North America LLC | 4 | $68 |
| Amgen Inc. | 3 | $50 |
| Viatris Specialty LLC | 3 | $42 |
| Verona Pharma, Inc. | 2 | $36 |
| Grifols USA, LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, Vest Therapy Und, YUPELRI, Ohtuvayre, Prolastin-C Liquid.
Industry payments across NJ — which companies pay providers there.
